GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 98 filers reported holding GENERATION BIO CO in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,807 | -99.9% | 510,354 | 0.0% | 0.28% | +19.0% |
| Q1 2023 | $2,194,522 | +9.4% | 510,354 | 0.0% | 0.23% | -7.2% |
| Q4 2022 | $2,005,691 | -26.0% | 510,354 | 0.0% | 0.25% | -26.1% |
| Q3 2022 | $2,710,000 | -19.1% | 510,354 | 0.0% | 0.34% | -13.1% |
| Q2 2022 | $3,348,000 | -10.6% | 510,354 | 0.0% | 0.39% | +2.6% |
| Q1 2022 | $3,746,000 | +3.7% | 510,354 | 0.0% | 0.38% | +11.5% |
| Q4 2021 | $3,613,000 | -71.8% | 510,354 | 0.0% | 0.34% | -54.8% |
| Q3 2021 | $12,795,000 | -7.2% | 510,354 | -0.4% | 0.75% | -5.4% |
| Q2 2021 | $13,782,000 | -5.5% | 512,349 | 0.0% | 0.79% | -2.7% |
| Q1 2021 | $14,581,000 | -1.4% | 512,349 | -1.7% | 0.82% | +1.6% |
| Q4 2020 | $14,783,000 | -5.5% | 521,460 | +3.0% | 0.80% | -6.9% |
| Q3 2020 | $15,649,000 | +47.2% | 506,273 | 0.0% | 0.86% | -5.1% |
| Q2 2020 | $10,632,000 | – | 506,273 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |